ScholarIQanswers from OpenAlex

Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis

PaperCitations, authors & open-access status

Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis have?

ScholarIQcitation count

Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis has 996 citations in the OpenAlex counts ScholarIQ stores.

When was Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis published?

ScholarIQyear

Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis has 2005 year in the ScholarIQ index.

What is the open-access status of Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis?

ScholarIQoa status

Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis has closed oa status in the ScholarIQ index.

What is the DOI of Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis?

ScholarIQdoi

The DOI for Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis is on the source record.

What is the PMID of Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis?

ScholarIQpmid

The PMID for Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis is on the source record.

What is the OpenAlex record for Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis?

ScholarIQopenalex

The OpenAlex for Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial